🇺🇸 FDA
Preview mode — showing bulk-ingested data not yet promoted to production. Hide preview

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
3,385
Companies
1,062
Pipeline programs
18,156

Quick answer

NovaPharmaNews tracks 3,385 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 11 of 142 · A–Z by INN

  1. atezolizumab

    TECENTRIQ

    INJECTION approved

    L01XC32

  2. atezolizumab and hyaluronidase-tqjs

    TECENTRIQ HYBREZA

    INJECTION approved

  3. atogepant

    AQUIPTA

    ORAL approved

    N02CD07

  4. atoltivimab

    INMAZEB Regeneron UK Limited

    INJECTION approved

  5. atomoxetine hydrochloride

    ATOMOXETINE HYDROCHLORIDE Teva Pharma GmbH

    ORAL approved

  6. atorvastatin calcium

    LYPQOZET Teva Pharma GmbH

    ORAL approved

  7. atosiban

    ATOSIBAN SUN

    G02CX01

  8. atovaquone

    ATOVAQUONE AND PROGUANIL HYDROCHLORIDE Amneal Pharma Europe Ltd

    ORAL approved

  9. atracurium besylate

    ATRACURIUM BESYLATE PRESERVATIVE FREE Teva Pharma GmbH

    INJECTION approved

  10. atrasentan hydrochloride

    VANRAFIA

    ORAL approved

  11. atropine

    ATROPINE SULFATE FGK

    INTRAMUSCULAR approved

    S01FA01

  12. atropine sulfate

    RYJUNEA Amneal Pharma Europe Ltd

    INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRAO approved

    S01FA01

  13. aumolertinib

    AUMSEQA

    L01EB

  14. auranofin

    RIDAURA

    ORAL approved

  15. autologous cartilage-derived articular chondrocytes, in-vitro expanded

    JELRIX

    M09AX02

  16. autologous cd34+ cells encoding arsa gene

    LIBMELDY

    N07

  17. autologous cd34+ enriched cell fraction that contains cd34+ cells transduced with retroviral vector that encodes for the human ada cdna sequence

    STRIMVELIS

    L03

  18. autologous glioma tumor cell lysates (inactivated)

    SITOIGANAP

    L01XX

  19. autologous human chondrocytes in vitro expanded

    ARTOBEND

    M09AX02

  20. autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-t)

    PROVENGE

    L03AX17

  21. avacincaptad pegol

    IZELVAY

    S01XA32

  22. avacincaptad pegol sodium

    IZERVAY

    INTRAVITREAL approved

  23. avacopan

    VYNPENTA (PREVIOUSLY AVACOPANCHEMOCENTRYX)

    ORAL approved

    L04

  24. avalglucosidase alfa

    NEXVIADYME

    A16

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 3,385 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources